Psychopharmacology Bulletin
-
Publication Venue For
- Effectiveness of a brain-computer interface based programme for the treatment of ADHD: a pilot study.. 43:73-82. 2010
- Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.. 42:11-31. 2009
- Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder.. 41:102-114. 2008
- Atypical antipsychotics and pituitary neoplasms in the WHO database.. 40:74-76. 2007
- Cognitive behavioral approaches to the treatment of pain.. 40:74-88. 2007
- Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.. 40:54-62. 2007
- Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study.. 40:47-56. 2007
- Evidence-based treatment of psychiatric disorders with comorbid medical illnesses: the need for large simple clinical trials.. 40:5-11. 2007
- Predicting antipsychotic use in children.. 40:116-124. 2007
- A randomized controlled trial of paroxetine for noncardiac chest pain.. 39:15-24. 2006
- Suicide risk analysis among patients assigned to psychotropics and placebo.. 39:6-14. 2006
- Alzheimer's disease and the glutamate NMDA receptor.. 37:41-49. 2003
- An evidence-based medicine approach to combined treatment for ADHD in children and adolescents.. 37:7-23. 2003
- Cholesterol-lowering medication and relapse of depression.. 37:92-98. 2003
- Continuation treatment of chronic depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination.. 37:73-87. 2003
- Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression.. 37:67-78. 2003
- Evidence for the treatment of borderline personality disorder.. 37:30-46. 2003
- Evidence-based decision-making in psychopharmacology.. 37:24-28. 2003
- Evidence-based mental health use of anticonvulsants during pregnancy.. 37:59-66. 2003
- Evidence-based practice: how to evaluate what you read.. 37:88-91. 2003
- Therapeutic implications of HPA axis abnormalities in Alzheimer's disease: review and update.. 37:120-134. 2003
- Treatment of posttraumatic stress disorder: the impact of paroxetine.. 37 Suppl 1:76-88. 2003
- Antipsychotic medications and sudden cardiac death.. 36:91-99. 2002
- Evidence-based mental health.. 36:27-34. 2002
- Management of late-life depression: focus on comorbid conditions.. 36:113-130. 2002
- Practical evidence-based medicine.. 36:20-26. 2002
- The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) approach.. 36:58-68. 2002
- Treatment of thyrotoxicosis-induced psychosis.. 36:7-13. 2002
- Clinical trials in Alzheimer's disease. Calculating Alzheimer's Disease Assessment Scale-cognitive subsection with the data from the consortium to establish a registry for Alzheimer's disease.. 35:83-96. 2001
- Informant-rated cognitive symptoms in normal aging, mild cognitive impairment, and dementia. Initial development of an informant-rated screen (Brief Cognitive Scale) for mild cognitive impairment and dementia.. 35:79-88. 2001
- Evidence report on: Treatment of depression - Newer pharmacotherapies. 34:409-795. 1998
- Pivotal studies of clonazepam in panic disorder.. 34:169-174. 1998
- Treatment of depression--newer pharmacotherapies.. 34:409-795. 1998
- Memory, language, and praxis in Alzheimer's disease: norms for outpatient clinical trial populations.. 33:123-128. 1997
- The Alzheimer's disease assessment scale .6. Noncognitive signs and symptoms in outpatients with Alzheimer's disease. 33:514-514. 1997
- A curbstone consult to applicants for National Institute of Mental Health grant support.. 32:311-320. 1996
- Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD).. 32:67-73. 1996
- The Alzheimer's Disease Assessment Scale: Predictors of baseline cognitive performance in clinical trials. 32:434-434. 1996
- From scientific knowledge to the clinical practice of psychopharmacology: can the gap be bridged?. 31:7-20. 1995
- Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.. 31:205-212. 1995
- Treatment optimization with ECT.. 30:313-320. 1994
- Diagnosis and treatment of depression in late life: the NIH Consensus Development Conference Statement.. 29:87-100. 1993
- Efficacy of treatments for major depression.. 29:457-475. 1993
- Does sigma receptor antagonism predict clinical antipsychotic efficacy?. 27:103-106. 1991
- Electroconvulsive therapy in the United States.. 27:9-15. 1991
- Predictors of therapeutic response to haloperidol in acute schizophrenia.. 27:97-101. 1991
- Meal-related cholecystokinin secretion in eating and affective disorders.. 25:444-449. 1989
- Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease.. 24:641-652. 1988
- Kraepelinian schizophrenia: a subgroup of schizophrenia?. 24:56-61. 1988
- The effects of amantadine vs. trihexyphenidyl on memory in elderly normal volunteers. 23:30-32. 1987
- Anticholinergic prophylaxis in young adults treated with neuroleptic drugs. 22:981-984. 1986
- ELECTRICAL DOSAGE, STIMULUS PARAMETERS, AND ELECTRODE PLACEMENT. 22:499-502. 1986
- Reliability and validity of SAFTEE: Preliminary analyses. 22:397-401. 1986
- The inventory of depressive symptomatology (IDS): Preliminary findings. 22:985-990. 1986
- The relationship between panic disorder and agoraphobia: an epidemiologic perspective.. 22:787-791. 1986
- A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression. 20:73-78. 1984
- The first clinical study of BW-234U in schizophrenia.. 18:173-176. 1982
- The role of stimulus waveform in therapeutic and adverse effects of ECT.. 18:71-72. 1982
- Cerebral blood flow in depression and mania. 18:6-8. 1982
- Efficacy of ECT in the treatment of depression: Wave form and electrode placement considerations. 18:31-34. 1982
- Evaluation of the central nervous system risks of ECT. 18:29-31. 1982
- Heterogeneity in the response pattern of organ systems to stress: Mediators and mechanisms. 18:96-99. 1982
- Model utility in postpartum psychosis. 18:184-187. 1982
- Biological and/or genetic factors in alcoholism.. 17:37-42. 1981
- Sleep EEG and dexamethasone suppression testing findings in unipolar depressions. 17:22-23. 1981
- The sympathetic nervous system as a model for studying drug-induced alterations of nerve development. 17:151-153. 1981
- Peripheral alpha-adrenergic receptor subtypes.. 16:90-91. 1980
- Drugs and psychotherapy in the treatment of depressions. 16:60-62. 1980
- The efficacy of new pharmacological treatments for panic disorder: evaluating the trials. 1998
- Algorithm for the treatment of panic disorder with agoraphobia. 1995
- Plasma GABA in mood disorders. 1990
- Posttraumatic stress disorder: Recent advances in basic science and clinical research 1989
- Pharmacotherapy in posttraumatic stress disorder: historical and clinical considerations and future directions. 1989